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Introduction
he death of a loved one is recognized as one of
life’s greatest stresses and has long been associated with
increased health risk, especially for the surviving spouse
or parent, although this is sometimes considered to be
incidental rather than bereavement-related. In 1963, a
follow-up of 4486 widowers, comparing their mortality
to that of married men,
1 reported a 40% increased mor-
tality rate in the first 6 months of bereavement, with lit-
tle differential thereafter. This finding, demonstrating a
relationship between spousal bereavement and adverse
health, has been confirmed.
2-4 In a recent study
2 bereaved
participants had a higher risk than nonbereaved partic-
ipants of dying from any cause (RR 1.27; 95% CI 1.2 to
1.35) including cardiovascular disease, coronary heart
disease, stroke, all cancer, smoking-related cancer, and
accidents or violence. In one 10-year follow-up study, it
was shown that increased health risk may continue for
many years after bereavement, especially in surviving
spouses (Figure 1).
5
While the increased health risk in bereavement is well
documented, the mechanism remains largely unex-
plained, possibly due to the perceived difficulties in con-
ducting research at a time of great distress. Proposed
explanations for the increased risk in bereaved individ-
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The death of a loved one is recognized as one of life’s
greatest stresses, with reports of increased mortality and
morbidity for the surviving spouse or parent, especially in
the early months of bereavement. The aim of this paper
is to review the evidence to date to identify physiological
changes in the early bereaved period, and evaluate the
impact of bereavement interventions on such physiologi-
cal responses, where they exist. Research to date suggests
that bereavement is associated with neuroendocrine acti-
vation (cortisol response), altered sleep (electroen-
cephalography changes), immune imbalance (reduced T-
lymphocyte proliferation), inflammatory cell mobilization
(neutrophils), and prothrombotic response (platelet acti-
vation and increased vWF-ag) as well as hemodynamic
changes (heart rate and blood pressure), especially in the
early months following loss. Additional evidence suggests
that bereavement interventions have the potential to be
of value in instances where sleep disturbance becomes a
prolonged feature of complicated grief, but have limited
efficacy in maintaining immune function in the normal
course of bereavement.
© 2012, LLS SAS Dialogues Clin Neurosci. 2012;14:129-139.
PAGES_13_AG_1001_BA.qxd:DCNS#52  6/06/12  12:06  Page 129uals include the tendency of unfit people to marry simi-
larly unfit spouses, and the possibility that the spouses
may share with the bereaved the same pathogenic envi-
ronment and dietary and social factors.
6,7 However, the
increased risk among the bereaved persists after adjust-
ment for spousal covariates,
8 bias from common socioe-
conomic environmental and common lifestyles, accidents
shared with spouses,
7 age, ethnicity, and education.
3 It is
therefore plausible that much of the increased health
risk in bereavement stems from the impact of psycho-
logical grief reactions on, or in conjunction with, physi-
ological responses, resulting in the early phases of
bereavement becoming a vulnerable period for the
bereaved person. 
The aim of this review is to document the evidence to
date, identify physiological changes in the early bereaved
period, and evaluate the impact of bereavement inter-
ventions on such physiological responses, where they
exist.
Neuroendocrine response
Neuroendocrine response during early bereavement has
been evaluated in several studies.
9-13 In one early study,
morning blood cortisol levels measured three times over
a 1- to 2-month period were not significantly higher in
anticipatory bereavement compared with nonbereaved
subjects, but were approximately 30% higher in the
bereaved group following the death of their husbands,
suggesting that bereavement, but not anticipatory
bereavement, is associated with increased adrenocorti-
cal activity.
10
This finding of elevated cortisol in the early period of
bereavement has been confirmed in several studies since,
at 10 days after unanticipated loss in one study,
12 and like-
wise 11 days after loss in a sample of bereaved spouses
and parents in another.
13 In this study
13 (Figure 2), men
had even higher cortisol levels than women, which was
accounted for by their self-reported increased alcohol
intake, possibly an indicator of vulnerability to stress.
It appears that cortisol remains elevated for at least the
first 6 months of bereavement.
12,13 For some, cortisol ele-
vation may become chronic, as observed in one study
that found increased afternoon saliva cortisol levels in
adults several years following parental loss in early child-
hood, with higher levels inversely associated with qual-
ity of life.
14
Cortisol, often referred to as a stress hormone, has
been previously associated with increased cardiac risk,
15
reduced immune function,
16 and reduced quality of
life.
14,17 Hypercortisolemia in bereavement may help
explain why some groups, mainly the elderly, are at
higher health risk compared with younger individuals.
This potential impact is highlighted in a recent study of
24 older bereaved adults that reported elevated blood
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Figure 1. Distribution of total morbidity rates per 100 person/ years in
bereaved and control cohorts in a 10-year follow-up of
bereaved spouses: A bereaved cohort and B control cohort.
The difference between groups in morbidity rates arose from
a general elevation in the distribution of morbidity incidence
among the bereaved, relative to the controls with morbidity
levels due to mental health (61% elevation, P=0.05) and cir-
culatory system disorders (66% elevation, P= 0.01) compared
with controls).
5
Figure reproduced from ref 5: Jones MP, Bartrop RW, Forcier L, Penny
R. The long-term impact of bereavement upon spouse health: a 10-
year follow-up. Acta Neuropsychiatrica. 2010;22:212-217. Copyright
© Wiley-Blackwell 2010
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levels compared with a matched nonbereaved control
group.
9 Both cortisol and DHEAS are outputs of the
hypothalamic-pituitary-adrenal (HPA) axis and a
higher ratio of cortisol to DHEAS is observed in older
age, as production of DHEAS, an immune enhancer,
decreases naturally whereas cortisol levels do not. As
such, elevated cortisol in a group with reduced ability
to produce DHEAS is likely to have greater impact in
elderly bereaved, with greater potential for immune
alteration. 
Disturbed sleep
Evidence of sleep disturbance in bereavement stems
from three main study approaches: community-based
studies,
18,19 self-reporting questionnaires following
bereavement, and quantification of sleep patterns using
electroencephalography (EEG). In one study conducted
in Sweden, the relative risk of sleep disturbances was
1.95 (CI = 1.5-3.4) in 509 widows whose husbands had
died from cancer 3 years prior compared with women
whose husbands were still alive.
18 In another study of
2800 randomly selected Japanese residents, bereavement
was associated with an increased risk of not maintaining
uninterrupted sleep and a higher incidence of using hyp-
notic medications (odds ratio of 1.65 and 2.12 respec-
tively).
19 Similarly, another study of 105 bereaved indi-
viduals, examined at least 6 months after their loss,
reported significantly lower sleep quality and efficiency,
with worse self-reported sleep measures associated with
higher levels of depression.
20
These reports of an association between bereavement
and altered sleep have been confirmed by studies using
electroencephalography (EEG) monitoring, although
studies have mainly focused on elderly samples. In one
study of 31 elderly bereaved spouses, stratified by the
presence or the absence of major depression 3.5 years
after loss, subjects with major depression had signifi-
cantly lower sleep efficiency, more early-morning awak-
ening, shorter rapid eye movement (REM) latency,
higher REM sleep percentage, and lower rates of delta
wave generation in the first non-REM (NREM) period,
compared with bereaved subjects without depression.
Interestingly in this study, sleep in bereavement without
depression was similar to that of nonbereaved control
subjects.
21 These findings have been confirmed in
another evaluation of 14 elderly bereaved subjects who
were experiencing subsyndromal depressive symptoms,
with evidence of diminished REM sleep latency, pro-
longed first REM sleep period, and impaired sleep effi-
ciency at 5.5 months following loss.
22
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Figure 2. Morning blood cortisol levels and self-reported hours of sleep in bereaved participants at 2 weeks (entry) and 6 months compared with
nonbereaved controls in the Cardiovascular Health in Bereavement Study.
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sleep in individuals with insomnia and may be one
mechanism underlying sleep disturbances in bereave-
ment. After controlling for the effects of age, time since
loss, and depression severity, greater frequency of
bereavement-related intrusive thoughts and avoidance
behaviors were associated with longer sleep latency and
lower deep sleep phases on EEG measurements in a
study of 40 men and women with major bereavement-
related depression 7.4 months after loss.
23 It is not sur-
prising that disturbed sleep patterns are a prominent fea-
ture of bereavement, as sleep disturbance is a prominent
feature of depressive symptomatology, affecting more
than 80% of people experiencing depression.
24,25 In
bereavement, reduced sleep time, likely a result of an
increased hypothalamic-pituitary-adrenal axis activation,
may exacerbate depressive symptoms since a strong
bidirectional relationship between sleep and depression
has been previously suggested.
26
While sleep disturbance can become persistent and
debilitating in some bereaved individuals, for most
uncomplicated bereavements, sleep returns to prebe-
reavement levels.
13,27 Preservation of normal sleep after
spousal bereavement has been previously associated
with fewer depressive symptoms in the first 2 years after
loss, with bereaved individuals who reported no depres-
sive symptoms recording normal sleep EEG patterns.
24
However, for those who develop complicated grief
(CG), a situation associated with negative health out-
comes
28 and increased risk of mortality in elderly,
29 sleep
disturbance has been suggested as an important thera-
peutic target in bereavement.
30
Immune/inflammatory changes
Immune function is one of the physiological changes
most studied to date in bereavement. Enumerative mea-
sures include quantifying the number of cells in various
subpopulations, usually using monoclonal antibodies
that bind to unique surface markers on cell types such
as T-lymphocyte cells or natural killer (NK) cells
16,31 and
functional measures usually conducted in vitro by mea-
suring antibody response to a specific antigen. 
One of the first studies to report immune changes in
early bereavement identified reduced T-lymphocyte
responses to mitogenic stimulation. In this work, 26
bereaved spouses were assessed at 2 and 8 weeks fol-
lowing loss and compared with a sample of nonbereaved
controls. Response to the mitogenic stimulant phyto-
hemagglutinin (PHA) was significantly depressed in the
bereaved group at 6 weeks after bereavement, but not
at the 2-week assessment.
32 Since this study, altered T-cell
responses have been reported following the death of a
loved one at 1 month following loss of a spouse,
33 at
approximately 12 months, but not at 6 months, following
loss or a close friend or lover in a sample of homosexual
men participating in a longitudinal study of HIV-1 infec-
tion
34 and at 40 days, although not at 10 days or 6 months,
following sudden death of a relative.
12
While research groups report reduced T-lymphocyte
proliferation in bereavement, it appears that the
absolute number of lymphocytes do not consistently
alter,
10-12 as only one study of bereaved parents showed
small changes in lymphocyte subpopulations,
35 suggest-
ing that parental response to the death of a child may be
different in some aspects of physiological response to
other bereaved groups. 
In addition to reduced T-lymphocyte responses, an asso-
ciation between reduced NK cell activity and bereave-
ment has been reported.
10,12 Natural killer cells, an impor-
tant defense against tumours and viral infections, were
higher in bereaved subjects with greater depression
scores and also with those reporting insomnia in one
study.
10 Additionally, a higher depression score was asso-
ciated with an absolute loss of suppressor/cytotoxic cells,
and an increase in the ratio of T helper to T suppres-
sor/cytotoxic cells in bereaved women,
36 lower
immunoglobulin-M levels at 4 to 6 weeks following loss
37
and reduced lymphocyte response in other bereaved
populations.
36,38
While evidence to date suggests that lymphocyte func-
tion may decrease in bereavement, more recent evi-
dence suggest neutrophils (nonspecific inflammatory
cells) may increase in number
39 and decrease in function
in elderly subjects during the early grieving period.
9 In a
prospective evaluation of 80 bereaved spouses at 2
weeks and 6 months following loss of a spouse or parent,
neutrophil count was significantly higher in bereaved
participants compared with a matched nonbereaved
sample at 2 weeks with reduction to nonbereaved levels
at 6 months.
39 Additionally, in this sample, smoking was
independently associated with this higher neutrophil
count, highlighting the complex potential interactions
between altered health behaviors and physiological
response. A recent evaluation of neutrophil function in
24 elderly bereaved subjects at 2 months following loss
Translational research
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response to a challenge with Escherichia coli (E. coli),
suggesting altered early ability to respond to an antigen
during the early months of bereavement in this elderly
population  (Figure 3).
9 While the significance of
increased leukocytes in bereavement is unclear to date,
inflammation plays a significant role in atherosclerosis,
and inflammatory markers, including leukocytes, corre-
late with cardiovascular mortality.
40,41
In the longer term, an unresolving grief response may be
a risk factor for altered immune response, as in one
study bereaved participants, who were characterized by
harm-avoidant temperament and long-lasting dysphoric
mood at 6 months following the unexpected death of
their spouse, had greater reduced immune responsive-
ness compared with participants whose grief levels were
significantly lower.
12 Coping style in bereavement may
also be a determinant of immune function in bereave-
ment,
34 and be associated with perceptions of better
health status 12 months following loss.
37
As identified earlier, timing of assessment appears
important, suggesting that immune imbalance is not an
immediate response in bereavement. Assessments in the
first few weeks of bereavement reported increased cir-
culation of inflammatory cells (neutrophils and
macrophages) but not changes to lymphocyte and NK
cells. However, assessments conducted 1 to 2 months
after loss have found altered immune response
(decreased lymphocyte and NK cell function) and in
assessments conducted after 6 months since loss normal
immune and inflammatory function was reported, except
for the bereaved who continued to demonstrate unre-
solved or sustained high levels of grief response. 
Hemodynamic response to bereavement
Heart rate
To date only two studies have reported on heart rate
(HR)during bereavement although increased HR has
been reported to be associated with psychological stress
in other life circumstances.
42-44 In the first of these stud-
ies 10 bereaved participants showed significantly higher
HR (approximately 5 beat differences) than either
depressed or control participants 2 months after loss.
This finding was confirmed in the Cardiovascular
Health in Bereavement (CARBER) study
42 in which
hourly measurements revealed significantly higher HR
in the acutely bereaved compared with the reference
group, whereas at 6 months HR in the bereaved had
fallen to nonbereaved levels (Figure 4). In CARBER,
higher HR was associated with higher levels of anxiety
and cortisol, suggesting that elevated HR in bereave-
ment is mediated by hypothalamic-pituitary-adrenal
axis activation. 
Elevated HR in bereavement may be a significant con-
tributor to health risk in early bereavement as higher
HR has been linked to greater cardiovascular risk and
mortality
45,46 and coronary artery plaque rupture.
47 In one
study of patients with existing heart disease, an increase
of five beats per minute in a 24-hour assessment, as seen
in the acutely bereaved participants in the CARBER
study,
42 increased the risk of new coronary events by
14%, after controlling for the other risk factors.
48 Lower
HR found in those taking HR-lowering medications in
the CARBER study,
42 while not surprising, would sug-
gest that these medications could be cardioprotective
during early bereavement,
49 especially in those who are
at significant cardiovascular risk. 
Blood pressure
Traumatic grief symptoms 6 months after the death of a
spouse predicted higher self-reported blood pressure
(BP) at 13- and 25-month follow-up in a prospective sur-
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Figure 3. Neutrophil superoxide production on stimulation with
Escherichia coli between bereaved and nonbereaved groups;
error bars are standard error of the mean.
Reproduced from ref 9: Khanfer R, Lord J, Phillips A. Neutrophil func-
tion and cortisol: DHEAS ratio in bereaved older adults. Brain Behav
Immun. 2011;25:1182-1186. Copyright © Academic Press 2011
1.6
1.8
2.0
2.2 *
2.4
2.6
Bereaved Control
L
o
g
1
0
 
S
u
p
e
r
o
x
i
d
e
 
p
r
o
d
u
c
t
i
o
n
 
t
o
 
E
.
c
o
l
i
PAGES_13_AG_1001_BA.qxd:DCNS#52  6/06/12  12:06  Page 133vey of 150 widows and widowers.
28 Higher clinic systolic
BP was reported in a sample of bereaved individuals,
compared with a control group, in a longitudinal study
of surviving spouses from deceased Alzheimer patients,
studied at 6-month intervals for 18 months.
50 Longer-
term raised BP was reported in family members of
deceased soldiers
51 where the stress of mourning was
associated with higher prevalence of hypertension after
controlling for other cardiac risk factors.
51 Over time, on
average 4 years, the proportion of hypertensive partici-
pants decreased suggesting that BP takes considerable
time to resolve after bereavement.
51
More recently, data from the CARBER study
42 suggests
that raised BP is a prominent physiological feature of
bereavement in the early grieving months, as 24-hour
ambulatory monitoring revealed a significantly higher
blood pressure load (percentage of day BP above 140
mm Hg) compared with nonbereaved matched controls
(39% vs 29%) at both 2 weeks and at 6 months follow-
ing loss, with older age independently associated with
higher BP levels.
42
While short-term hemodynamic changes, as reported
above, may have limited clinical significance for healthy
younger individuals, small changes could increase risk
for older individuals or those with known cardiovascu-
lar disease (CVD). For example, a 2-mm Hg reduction
in mean systolic BP has been associated with 7% lower
CVD and 10% lower risk of stroke and death,
52 making
BP a potential target for preventative strategies in
bereavement. 
Platelet activation and coagulation factors
Increased levels of circulating Von Willebrand factor
(vWF) and increased platelet activation have been
recently observed in the early weeks of bereavement,
with both changes resolved 6 months later (Figure 4).
39
Von Willebrand factor, a major hemostatic regulatory
molecule synthesised by endothelium and involved in
platelet aggregation, has previously been associated with
post-traumatic stress
53 and clinical depression
54,55 and is
an independent risk factor for myocardial infarction.
56
The finding of increased platelet activation may partially
contribute to increased CV risk in those already with
pre-existing risk factors. Circulating activated platelets
play an important role in thrombosis
57 and most, but not
all, acute coronary occlusions occur as the result of rup-
ture of an unstable atherosclerotic plaque and superim-
posed thrombus formation
58 As such, one approach to
cardiovascular prevention for those at increased risk in
Translational research
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Figure 4. vWF-ag levels and 24-hour average HR in bereaved participants at 2 weeks (entry) and 6 months compared with nonbereaved controls in
the Cardiovascular Health in Bereavement Study.
42 vWF, von Willebrand factor
100
110
120
*
*
130
Entry
6 months
vWF-ag (mean +/- SE)
Bereaved Control
* P<0.05 * P<0.05
v
W
F
-
a
g
 
(
%
)
60.00
65.00
70.00
75.00
*
*
80.00
Entry
6 months
24-hour average heart rate (mean +/- SE)
Bereaved Control
H
e
a
r
t
 
r
a
t
e
 
(
b
p
m
)
PAGES_13_AG_1001_BA.qxd:DCNS#52  6/06/12  12:06  Page 134bereavement could be short-term use of antithrombotic
medications, such as aspirin, in the early weeks of
bereavement, as has been previously proposed for other
transient periods of increased risk.
49
The effect of bereavement interventions on
physiological correlates
Neuroendocrine
Specific interventions designed to reduce cortisol
response in bereavement have not been reported,
although a randomized controlled clinical trial that
examined the effect of support group sessions on
immune response reported significantly lower plasma
cortisol levels in the intervention group compared with
the control group following 10 weekly 90-minute sup-
port group sessions.
59 In this study, a reduction in physi-
cian visits was also reported in the intervention group,
59
although it is unclear which aspect of the intervention
contributed to these findings. 
Sleep
To date two intervention approaches to improve sleep
in CG have been reported; one a nonpharmacological
approach and the other using a tricyclic antidepressant
medication. Findings from one study suggest that a 16-
week Complicated Grief Treatment (CGT) intervention
has the potential to improve sleep, albeit modestly, in
individuals suffering CG.
60 In this study of 67 bereaved
individuals with elevated scores greater than or equal to
30 on the Inventory of Complicated Grief,
61 suggestive
of intense grief reactions, subjects who were randomized
to receive the CGT intervention reported lowered grief
scores although scores remained elevated in participants
after treatment, and they continued to experience clin-
ically significant sleep problems.
61
The potential effectiveness of cognitive behavioral ther-
apy was highlighted in another study of 11 recently
bereaved family members.
62 In this study, the interven-
tion consisted of cognitive behavioral therapy-insomnia
(CBT-I) which included educational information about
cognitive restructuring, stimulus control, sleep hygiene,
relaxation techniques and goal setting, and monitoring.
Self-reported sleep measures and depression scores
decreased over the 5-week intervention period, although
sleep actigraphy data (that provide limited measures of
sleep patterns and circadian rhythms) showed no signif-
icant changes over the study period. However, this study
was limited by not including a control group to help
determine whether the improvement was related to the
treatment or the natural course of bereavement and the
limitations of using actigraphy as a sleep measure. 
Use of nortriptyline appears to improve sleep quality in
elderly bereaved, although removal of the treatment
appeared to result in loss of some effect.
63,64 In one study
10 elderly bereaved subjects, compared with matched
healthy controls, were monitored using EEG study tech-
niques while on and after discontinuation of nortripty-
line, remission of depressive symptoms while still on
treatment was associated with significant improvements
in sleep EEG measures and sleep efficiency. In this study
sleep quality continued to show improvement coincident
with sustained clinical remission after ceasing treatment,
suggesting that nortriptyline may be clinically useful in
treating sleep disturbances in older people with bereave-
ment-related depression.
22
Taylor and colleagues
64 built on the above studies by
conducting a double-blind, randomized controlled trial
to examine the effect of nortriptyline on depressive
symptoms and sleep quality, employing EEG sleep study
measures in 27 elderly bereaved participants, all diag-
nosed with depression within 7 weeks of their loss. The
16-week intervention was associated with better EEG
measures while on treatment at 4 months compared with
a placebo group, but not at 6 months, which was 2
months after discontinuation of treatment, suggesting
that EEG sleep characteristics in bereavement-related
depression persist into remission. 
Immunity
Four studies have reported the outcome of interventions
to enhance immune function in bereavement, two
demonstrating no intervention effect
65,66 while two stud-
ies found potential benefit for individuals with HIV.
59,67
In one randomized controlled trial of 18 middle-aged
Dutch widows, recruited 3 months after loss, no differ-
ences were found between groups in psychological or
immune measures following a 4-month group grief coun-
selling program.
65 Similarly, another study testing the
effect of relaxation sessions on grief, stress symptoms,
and immune response functioning in a sample of 27
bereaved widows reported no intervention effect despite
a reduction in psychological grief symptoms. However,
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behavioral interventions to have beneficial immunolog-
ical and clinical health effects following bereavement
among HIV-1-infected individuals was highlighted.
59 In
this study, support group sessions were associated with
reduced blood cortisol levels and fewer physician visits,
and a stable CD4
+ cell count for the intervention group
over the 6-month study period, whereas the CD4
+ cell
count decreased in HIV-positive participants in the con-
trol group.
59This same research group suggested that the
bereavement support group intervention may prove to
be not only a primary therapy for psychological distress
but also an adjunctive therapy for sustained control of
plasma viral load in conjunction with highly active anti-
retroviral therapy in this population with pre-existing
immune depression.
67
Discussion
Despite the difficulties in conducting physiologically
based studies in the early bereavement period, current
evidence suggests that such a severely distressing life
event is associated with increased cortisol secretion that
potentially contributes to increased cognitive arousal
resulting in sleep disturbance, especially in those with
intense or prolonged grief reactions. It is likely that cor-
tisol secretion and disruptions to sleep partially con-
tribute towards or exacerbate immune, hemodynamic,
and prothrombotic responses, especially in the early
months following loss and in those where grief intensity
is particularly high (Figure 5). 
The impact of bereavement interventions on physiolog-
ical correlates is difficult to ascertain due to the limited
number of controlled intervention studies to date and
the limitation of studies conducted in predominantly
elderly populations. Both use of CGT and norytriptyline
therapies show potential promise in instances where
sleep disturbance becomes a prolonged feature of CG,
especially in older people, although further randomized
controlled studies with adequately powered samples and
longer term follow-up data are required before such
therapies could be recommended broadly.
While bereavement is associated with increased mobi-
lization of inflammatory cells and changes in immune
function, it is unclear if the temporary changes are
causally related to the increased health risk. Evidence to
date suggests that bereavement interventions to pro-
mote immune function have limited use in the normal
course of bereavement, except in populations with pre-
existing immunosuppression, where evidence suggests a
role preventing decline in immune function. 
Recent prospectively gathered evidence of hemody-
namic and prothrombotic changes in the early weeks of
bereavement provide insight into the impact of early
bereavement on known cardiac risk factors and inform
potential preventative approaches to reduce cardiovas-
cular risk during this heightened vulnerable period, espe-
cially in those already at increased risk.
One noninvasive potential preventative approach in
bereavement may be to focus on modifying or avoiding
behaviors, such as tobacco smoking, alcohol consump-
tion, and changes to diet, that, in the presence of altered
physiology, could further increase health risk.
Additionally, reducing the risk of acquiring infections by
implementing simple preventative strategies such as fre-
quent handwashing may also be useful, since immune
imbalance appears prevalent during early bereavement. 
While being prepared for a loved one’s death can result
in decreased psychological stress symptoms,
13 there is a
lack of studies on the effects of anticipatory bereave-
ment on physiological correlates, a potential area of
future research. In samples where mortality risk is
reported in surviving spouses, no difference between
expected deaths and unexpected deaths has been
reported.
68 However, the anticipatory bereavement
period may provide opportunity for potential preventa-
tive strategies targeting health outcome. Indeed, it is
Translational research
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Figure 5. Representation of the complex interactions between psycho-
logical and physiological correlates of bereavement. 
Bereavement-related depression/ anxiety symptoms
Cognitive arousal
Sleep disturbance  Increased hemodynamic load
Immune/ Inflammatory/prothrombotic response
Neuroendocrine activation
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study
69 that compared mortality risk among 30 838 cou-
ples where the deceased used hospice care and an equal
number of couples where the deceased did not, analysis
of spousal mortality revealed that bereaved spouses
whose deceased partners had used hospice services, com-
pared with “control bereaved” subjects who did not,
were less likely to die themselves in the first 18 months
of bereavement, with an adjusted odds ratio of 0.92 for
widows and 0.95 for widowers. This study highlights the
possible protective influence of social support during the
anticipatory bereavement period on spousal outcome. In
this study, hospice care was described as including nurs-
ing services, physician visits, homemaker assistance,
social assistance, and bereavement counseling.
The focus at the time of bereavement is naturally
directed to the deceased person; the health and welfare
of bereaved survivors is of concern to both surviving
family members and their health care practitioners.
Further research is warranted, building on the body of
evidence to date, to continue to prospectively evaluate
physiological correlates in bereavement and also to test
preventive interventions targeted at reducing health risk
during this universal and inevitable life stressor.  ❏
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Correlato fisiológico del duelo y el impacto
de las intervenciones sobre el duelo
La muerte de un ser querido es reconocida como
uno de los mayores estresores de la vida, especial-
mente en los primeros meses del duelo, lo que se
basa en reportes del aumento de la morbi-mortali-
dad de la esposa o del padre sobreviviente. El obje-
tivo de este artículo es revisar la evidencia disponi-
ble a la fecha para identificar los cambios
fisiológicos en el primer período del duelo y evaluar
el impacto de las intervenciones sobre éste en las
respuestas fisiológicas cuando ellas se presentan. La
investigación actual sugiere que el duelo se asocia
especialmente en los primeros meses que siguen a
la pérdida con: activación endocrina (respuesta de
cortisol), sueño alterado (cambios electroencefalo-
gráficos), desbalance inmune ((proliferación redu-
cida de linfocitos T), movilización de células infla-
matorias (neutrófilos), respuesta protrombótica
(activación plaquetaria y aumento del antígeno de
Factor von Willebrand) y también hemodinámicos
(frecuencia cardíaca y presión sanguínea). La evi-
dencia adicional sugiere que las intervenciones
sobre el duelo son potencialmente valiosas en situa-
ciones donde el trastorno del sueño se constituye
en una característica prolongada del duelo compli-
cado, pero tienen una eficacia limitada en el man-
tenimiento de la función inmune durante el curso
normal del duelo.     
Corrélats physiologiques d’une perte affective
et impacts des interventions sur cette perte
La perte d’un être aimé est reconnue comme étant
l’un des stress les plus importants de la vie, avec une
morbidité et une mortalité augmentées chez
l’époux ou le parent survivant, surtout dans les mois
qui suivent la perte. Le but de cet article est d’ana-
lyser les preuves actuelles des modifications phy-
siologiques de la période précoce qui suit cette
perte et d’évaluer l’impact des interventions sur ces
réponses physiologiques, là où elles existent.
Jusqu’à présent, la recherche suggère qu’une perte
affective est associée à une activation neuroendo-
crinienne (réponse cortisolique), un sommeil altéré
(modifications électroencéphalographiques), un
déséquilibre immunitaire (prolifération diminuée
des lymphocytes T), une mobilisation des cellules de
l’inflammation (neutrophiles), une réponse pro-
thrombotique (activation plaquettaire et augmen-
tation des antigènes du facteur von Willebrand soit
vWF-ag) ainsi que des modifications hémodyna-
miques (fréquence cardiaque et pression artérielle),
surtout dans les mois qui suivent la perte. Des
preuves supplémentaires suggèrent que les inter-
ventions après une perte affective peuvent avoir un
effet dans les cas où les perturbations du sommeil
prolongent un deuil compliqué mais elles sont peu
efficaces sur le maintien de la fonction immunitaire
au cours de l’évolution normale du deuil.
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